In this article, we will discuss the 11 Debt Free Halal Stocks to Buy.

Jitters in the US equity market are rising as concerns about artificial intelligence, a looming software-as-a-service downturn, and ongoing conflict in the Middle East unsettled investors. Major indices have already declined, with the S&P 500 down by 1.8% year to date, reflecting increased selling pressure as investors take profits amid persistent headwinds.

Jack Janasiewicz, portfolio manager at Natixis Investment Managers, notes that the market downturn reflects heightened concerns about stagflation, particularly amid rising energy costs.

“There’s a risk here going forward of this being a protracted issue and it all comes back to that oil price,” he said. “You’ve got a little bit of potential for reprising inflation expectations, but at the same time you got to think about the demand destruction.”

According to Goldman Sachs strategist Peter Oppenheimer, the equity market is exhibiting characteristics similar to those observed before the 2007 financial crisis. In a recent research note, Oppenheimer highlighted that equity risk premia—which measures the excess return investors demand over safer assets—have fallen to levels seen during the financial crisis. Despite declining investor confidence, Oppenheimer is not forecasting a bear market but advises caution regarding a potential correction from current highs.

“We see correction risks as high given current valuations,” Oppenheimer wrote, “but expect this to present a buying opportunity with relatively low risk of a more protracted and deep bear market.”

In light of these uncertainties, maintaining broad geographic, sector, and factor diversification remains essential. Diversification, however, means not only holding different assets but also selecting those that remain resilient under varying pressures.

Debt-free halal stocks are well-positioned for portfolio diversification, offering stability and alignment with Islamic principles. These stocks represent financially sound companies with limited debt exposure.

Our Methodology

To compile this list, we began by reviewing the S&P Shariah ETF, which contains all Shariah-compliant constituents of the larger S&P index and adheres to Islamic principles. We then settled on companies that demonstrate strong financial health, as evidenced by low net debt, healthy cash reserves, and an enterprise value (EV) to their market capitalization (EV-to-market cap ratio) of less than 1. We then shortlisted those stocks with upside potential above 10% based on consensus analyst estimates. The final ranking reflects each stock’s calculated upside potential and the level of hedge fund ownership, which offers additional insight into institutional confidence.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research shows we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).

Debt-Free Halal Stocks to Buy

11. AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) is one of the debt free halal stocks to buy. On March 3, at the TD Cowen 46th Annual Health Care Conference, AbbVie Inc. (NYSE:ABBV) affirmed its robust research and development pipeline, commercial strategies, and future growth plans.

The company reiterated that it is on course to achieve a high single-digit compound annual growth rate through 2029. The growth will be driven by a diversified pipeline as the company increasingly focuses on bolstering its immunology, oncology, and neuroscience, with promising assets like SKYRIZI and RINVOQ.

AbbVie is also exploring B-cell-depleting strategies and mRNA-based CAR-T therapies for rheumatologic diseases. It’s also leveraging its expertise in immunology and CNS to develop an obesity drug. Even as it continues developing its pipeline, it is launching tavapadone to target a $5 billion market opportunity in Parkinson’s disease.

The pipeline development and launch of new drugs come on the heels of AbbVie increasing its research and development expenditure, with over $8 billion already spent on business development over the past two years.

AbbVie Inc. (NYSE:ABBV) is a global research-driven biopharmaceutical company focused on discovering, developing, and commercializing advanced therapies for complex, serious diseases. Key areas include immunology, oncology, neuroscience, eye care, and aesthetic medicine (via Allergan).

10. Micron Technology, Inc. (NASDAQ:MU)

Micron Technology (NASDAQ:MU) is one of the debt free halal stocks to buy. On March 12, Mizuho kept its Outperform rating on Micron Technology (NASDAQ:MU) and set a price target of $480. This came just before Micron’s earnings report on March 18.

Mizuho expects Micron’s results to be stronger than Wall Street’s forecasts. For the May quarter, they see $25 billion in revenue and $11.13 earnings per share (EPS), which is about 8% higher than consensus. For the August quarter, they project $27.2 billion in revenue and $12.25 EPS, about 7% above consensus.

The firm believes Micron will benefit from higher prices for DRAM and NAND chips, while supply growth remains limited. They also expect big cloud companies (hyperscalers) to boost spending by nearly 60% in 2026.

Demand for HBM3e memory is strong ahead of HBM4, with prices expected to be 30–45% higher. LPDDR5 demand is also rising, with Rubin chips carrying three times more content than Blackwell.

NAND chips are seeing support from AI‑driven demand for QLC eSSD and new technology upgrades expected in 2026–27. Overall, Mizuho sees a strong memory market, tight supply, and AI demand driving better pricing and margins for Micron.

Micron Technology, Inc. (NASDAQ:MU) is a leading American semiconductor company that designs, manufactures, and sells high-performance memory and storage technologies, including DRAM, NAND flash, and NOR memory.